191 Spam-Free Article(s) Found
Sort:
Relevance
Like
Date
Filter:
7d
All
DeepLinks
Article Searches
Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2244869/wall-street-analysts-see-a-101-81-upside-in-lyra-therapeutics-lyra-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2244869 Mar 22, 2024 - The consensus price target hints at a 101.8% upside potential for Lyra Therapeutics (LYRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
U.S. Stocks Seeing Modest Weakness Amid Cautious Trading https://www.rttnews.com/story.aspx?Id=3434582 Mar 25, 2024 - Following the lackluster performance seen during last Friday's session, stocks are seeing modest weakness during trading on Monday. The major averages have all moved to the downside after ending the previous session mixed. Currently, the major averages are off their lows of the session but still in the red.
Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2245514/wall-street-analysts-see-a-76-89-upside-in-mediwound-mdwd-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2245514 Mar 25, 2024 - The mean of analysts' price targets for MediWound (MDWD) points to a 76.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See D-WAVE QUANTUM (QBTS) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2245422/wall-street-analysts-see-d-wave-quantum-qbts-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2245422 Mar 25, 2024 - Based on the average brokerage recommendation (ABR), D-WAVE QUANTUM (QBTS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Wall Street Analysts See a 71.71% Upside in Phunware (PHUN): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2245517/wall-street-analysts-see-a-71-71-upside-in-phunware-phun-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2245517 Mar 25, 2024 - The mean of analysts' price targets for Phunware (PHUN) points to a 71.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Plains All American Pipeline (PAA) Sees a More Significant Dip Than Broader Market: Some Facts to Know https://www.zacks.com/stock/news/2246359/plains-all-american-pipeline-paa-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2246359 Mar 26, 2024 - In the latest trading session, Plains All American Pipeline (PAA) closed at $17.07, marking a -0.52% move from the previous day.
Wall Street Analysts See Qualcomm (QCOM) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2245941/wall-street-analysts-see-qualcomm-qcom-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2245941 Mar 26, 2024 - The average brokerage recommendation (ABR) for Qualcomm (QCOM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Bayer-backed Boundless Bio sees stock fall 8% after $100M IPO https://seekingalpha.com/news/4085101-bayer-backed-boundless-bio-stock-falls-after-100m-ipo?source=feed_sector_healthcare Mar 28, 2024 - Bayer-backed Boundless Bio (BOLD) saw its shares drop 8% following a $100M initial public offering on Thursday. Read more here.
Wall Street Analysts See a 25.67% Upside in Burford Capital (BUR): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2247409/wall-street-analysts-see-a-25-67-upside-in-burford-capital-bur-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2247409 Mar 28, 2024 - The consensus price target hints at a 25.7% upside potential for Burford Capital (BUR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See an 82.29% Upside in Xperi (XPER): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2247411/wall-street-analysts-see-an-82-29-upside-in-xperi-xper-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2247411 Mar 28, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 82.3% in Xperi (XPER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Pages: 1234567891011...20

<<<Page 6>